CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $77,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-11 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | KABAKOFF DAVID S Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +16,083 | 16,083 | ||
| 2020-06-11 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +28,500 | 28,500 | ||
| 2020-02-28 | Bingham James B. Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,200 | 78,200 | ||
| 2020-02-28 | Cobourn Steven P. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,200 | 78,200 | ||
| 2020-02-28 | Heller Kevin N. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,050 | 100,050 | ||
| 2020-02-28 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,200 | 78,200 | ||
| 2020-02-28 | Liu Linda SVP, Research | Grant or award · Employee Stock Option (Right to Buy) | +39,100 | 39,100 | ||
| 2020-02-28 | Mayer Timothy Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,200 | 78,200 | ||
| 2020-02-28 | Richman Michael President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2019-11-27 | Liu Linda SVP, Research | Option exercise | +34,489 | $0.48 | $17K | 34,489 |
| 2019-11-27 | Liu Linda SVP, Research | Option exercise | +20,745 | $1.21 | $25K | 55,234 |
| 2019-11-27 | Liu Linda SVP, Research | Option exercise · Employee Stock Option (Right to Buy) | −34,489 | 9,076 | ||
| 2019-11-27 | Liu Linda SVP, Research | Option exercise · Employee Stock Option (Right to Buy) | −20,745 | 10,373 | ||
| 2019-11-15 | Sofinnova Venture Partners IX, L.P. 10% owner | Purchase | +150,000 | $36.75 | $5.5M | 2,671,856 |
| 2019-06-13 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2019-06-13 | KABAKOFF DAVID S Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2019-06-13 | Khuong Chau Quang Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2019-06-13 | Li Judith Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 7 of 10 · 197 trades